메뉴 건너뛰기




Volumn 65, Issue 1, 2006, Pages 133-

Inadequate growth hormone (GH) suppression following an octreotide test dose predicts the need for adjuvant therapy to achieve 'safe' GH levels [2]

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; OCTREOTIDE;

EID: 33745208428     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02549.x     Document Type: Letter
Times cited : (1)

References (4)
  • 1
    • 20444432736 scopus 로고    scopus 로고
    • The nadir growth hormone after an octreotide test dose predicts the long-term efficacy of somatostatin analogue therapy in acromegaly
    • Gilbert J.A. Miell J.P. Chambers S.M. McGregor A.M. Aylwin S.J.B. ( 2005) The nadir growth hormone after an octreotide test dose predicts the long-term efficacy of somatostatin analogue therapy in acromegaly. Clinical Endocrinology, 62, 742 747.
    • (2005) Clinical Endocrinology , vol.62 , pp. 742-747
    • Gilbert, J.A.1    Miell, J.P.2    Chambers, S.M.3    McGregor, A.M.4    Aylwin, S.J.B.5
  • 2
    • 33644670829 scopus 로고    scopus 로고
    • Poor responses to a test dose of subcutaneous octreotide predict the need for adjuvant therapy to achieve 'safe' growth hormone levels
    • Lindsay J.R. McConnell E.M. Hunter S.J. McCance D.R. Sheridan B. Atkinson A.B. ( 2005) Poor responses to a test dose of subcutaneous octreotide predict the need for adjuvant therapy to achieve 'safe' growth hormone levels. Pituitary, 7, 139 144.
    • (2005) Pituitary , vol.7 , pp. 139-144
    • Lindsay, J.R.1    McConnell, E.M.2    Hunter, S.J.3    McCance, D.R.4    Sheridan, B.5    Atkinson, A.B.6
  • 3
    • 19944381531 scopus 로고    scopus 로고
    • Intravenous octreotide test predicts the long term outcome of treatment with octreotide-long-acting repeatable in active acromegaly
    • Biermasz N.R. Pereira A.M. Smit J.W.A. Romijn J.A. Roelfsema F. ( 2005) Intravenous octreotide test predicts the long term outcome of treatment with octreotide-long-acting repeatable in active acromegaly. Growth Hormone and IGF Research, 15, 200 206.
    • (2005) Growth Hormone and IGF Research , vol.15 , pp. 200-206
    • Biermasz, N.R.1    Pereira, A.M.2    Smit, J.W.A.3    Romijn, J.A.4    Roelfsema, F.5
  • 4
    • 15044348198 scopus 로고    scopus 로고
    • The value of an octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly
    • Karavitaki N. Botusan I. Radian S. Coculescu M. Turner H.E. Wass J.A.H. ( 2005) The value of an octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly. Clinical Endocrinology, 62, 282 288.
    • (2005) Clinical Endocrinology , vol.62 , pp. 282-288
    • Karavitaki, N.1    Botusan, I.2    Radian, S.3    Coculescu, M.4    Turner, H.E.5    Wass, J.A.H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.